Lucid Diagnostics Secures VA Contract for EsoGuard Test, Expanding Esophageal Precancer Testing Across Veterans Affairs Healthcare Facilities.

Lucid Diagnostics (LUCD) has secured a contract with the US Department of Veterans Affairs for its EsoGuard Esophageal DNA Test, expanding availability across the VA healthcare system. The contract aligns with Medicare reimbursement rates and facilitates streamlined procurement. LUCD operates in the healthcare sector, focusing on medical diagnostics technology for esophageal precancer detection. The company has demonstrated revenue growth but faces significant negative margins and financial distress.